Loading clinical trials...
Loading clinical trials...
This was a non-interventional, prospective, multi-center real world setting study, aiming to provide safety and effectiveness data in Chinese pediatric patients with moderate to severe plaque psoriasi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT06591273 · Moderate to Severe Chronic Plaque Psoriasis
NCT03410992 · Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, and more
NCT03536884 · Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis
NCT03370133 · Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, and more
NCT03598790 · Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis
Novartis Investigative Site
Guangzhou, Guangdong
Novartis Investigative Site
Shijiazhuang, Hebei
Novartis Investigative Site
Zhengzhou, Henan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions